FirmaIQ
Org.nr 932 567 768 2024 → 2025 Year-over-year analysis

AKER BIOMARINE HUMAN INGREDIENTS AS: årsregnskap 2025 vs 2024

Grew 18% on revenue, returned to profit, fresh owner capital

approved 2026-05-28; registry 2026-07-04; journal 2026 534187

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2025 with 2024 for AKER BIOMARINE HUMAN INGREDIENTS AS. Revenue 96.64m NOK → 113.72m NOK (+17.7%). Net result -39.81m NOK → +8.52m NOK. Equity -14.04m NOK → 56.62m NOK.

On the constructive side: revenue rose; operating result improved; turned profitable.

Net constructive year on the published lines.

At a glance

Scorecard

Revenue
96.64m NOK 113.72m NOK
+17.7%
Operating result
-36.71m NOK +13.27m NOK
+136.1%
Net result
-39.81m NOK +8.52m NOK
+121.4%
Equity
-14.04m NOK 56.62m NOK
+503.4%
Cash
147.1k NOK 180.5k NOK
+22.7%
Total assets
113.14m NOK 148.53m NOK
+31.3%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 96.64m NOK to 113.72m NOK (+17.7% YoY). Calculated

  • ↑

    Operating result improved

    Operating result -36.71m NOK → +13.27m NOK (op. margin -38.0% → 11.7%). Calculated

  • ↑

    Turned profitable

    Net result flipped from a loss of 39.81m NOK to a profit of 8.52m NOK. Calculated

  • ↑

    Equity strengthened

    Book equity -14.04m NOK → 56.62m NOK (equity ratio -12.4% → 38.1%). Calculated

  • ↑

    Cash rose

    Bank deposits 147.1k NOK → 180.5k NOK (+22.7% YoY). Calculated